Gilead Sciences
GILD
#103
Rank
$187.58 B
Marketcap
$151.28
Share price
-0.61%
Change (1 day)
34.33%
Change (1 year)

Gilead Sciences (GILD) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : $37.61 Billion USD

According to Gilead Sciences's latest financial reports the company's total liabilities are $37.61 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Gilead Sciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31$36.40 B-8.41%
2024-12-31$39.74 B0.95%
2023-12-31$39.37 B-6.16%
2022-12-31$41.96 B-10.51%
2021-12-31$46.88 B-6.57%
2020-12-31$50.18 B28.76%
2019-12-31$38.97 B-7.51%
2018-12-31$42.14 B-15.35%
2017-12-31$49.78 B32.35%
2016-12-31$37.61 B15.37%
2015-12-31$32.60 B73.01%
2014-12-31$18.84 B73.94%
2013-12-31$10.83 B-7.37%
2012-12-31$11.69 B12.08%
2011-12-31$10.43 B90.75%
2010-12-31$5.47 B71.32%
2009-12-31$3.19 B29.22%
2008-12-31$2.47 B10.6%
2007-12-31$2.23 B0.78%
2006-12-31$2.21 B200.21%
2005-12-31$0.73 B159.05%
2004-12-31$0.28 B-48.33%
2003-12-31$0.55 B-23.03%
2002-12-31$0.71 B109.39%
2001-12-31$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
$116.09 B 208.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$115.63 B 207.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$141.00 B 274.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$108.40 B 188.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$83.95 B 123.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$13.23 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$3.88 B-89.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$7.17 B-80.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$87.81 B 133.45%๐Ÿ‡บ๐Ÿ‡ธ USA